Global Autism Disorder and Treatment- Market

Autism Disorder and Treatment- Comprehensive Study by Therapy (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants, Stimulants, Sleep Medications, Others), Type (Autistic disorder, Asperger Syndrome, Pervasive Developmental Disorder, Others), End User (Hospitals, Medical Institutions, Research and development centers, Others) Players and Region - Global Market Outlook to 2030

Autism Disorder and Treatment- Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Autism Disorder and Treatment-
Autism Disorder is a neurodevelopmental disorder that affects communication, social interaction, and behaviour. It is called a spectrum disorder as it can manifest in a wide range of symptoms and severity levels. While a diagnosis of autism can occur at any point it is categorized as a developmental disorder due to the typical manifestation of symptoms within the initial two years of life. For instance, according to the World Health Organization (WHO), About 1 in 100 children has autism. The treatment for autism spectrum disorder (ASD) typically involves a combination of behavioural, educational, and therapeutic interventions tailored to address individual needs. there is no cure for autism, but early and comprehensive interventions can significantly improve outcomes.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Billion)
CAGR6.7%


Companies are launching Autism Disorder Treatment programs as a combination of social, ethical, and business considerations. As awareness of autism spectrum disorder (ASD) increases, there is a growing demand for specialized treatments and interventions. Companies are recognizing the market potential in providing services and products catering to individuals with autism and their support networks. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Autism Disorder and Treatment- market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Novartis AG (Switzerland), Curemark, LLC (United States), Yamo Pharmaceuticals (United States), H. Lundbeck A/S (Denmark), Pfizer Inc. (United States), Allergan (Ireland), Merck & Co., Inc. (United States), Concern Pharma Private Limited (India), Johnson & Johnson Services, Inc. (United States) and Bristol-Myers Squibb (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are PaxMedica (United States), Hoffmann-La Roche Ltd (Switzerland), Aurobindo Pharma Ltd. (India), Otsuka Holdings Co. Ltd. (Japan) and Janssen Pharmaceuticals, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Autism Disorder and Treatment- market by and Region.



On the basis of geography, the market of Autism Disorder and Treatment- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Therapy, the sub-segment i.e. Antipsychotic Drugs will boost the Autism Disorder and Treatment- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Type, the sub-segment i.e. Autistic disorder will boost the Autism Disorder and Treatment- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Autism Disorder and Treatment- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing emphasis on early diagnosis and intervention for individuals with autism disorder and Increasing the integration of technology in autism treatment

Market Growth Drivers:
Growing awareness and understanding of autism disorder, with the growing treatment options in the market and Government initiatives towards the infrastructure for autism disorder treatment

Challenges:
Difficulties in obtaining and covering the costs of these treatments

Restraints:
The utilization of medications carries the potential for the manifestation of side effects.

Opportunities:
Increasing research and development for the treatment of autism disorder and The increasing adoption and endorsement of therapies for the surge in implementation and approval.

Market Leaders and their expansionary development strategies
In January 2021, Autism Care Partners announced the acquisition of Puddingstone Place, now it is one of the prominent providers of Applied Behaviour Analysis (ABA) and associated therapies in the state of Massachusetts.
In September 2023, The Marcus Autism Center introduced a diagnostic technology that relies on biomarkers and eye-tracking a significant advancement in the diagnosis of autism. Which is the first biomarker-based tool developed by the company.


Key Target Audience
Drug Manufacturers, Regulatory Bodies, Potential Investors, Research and Development Institutes, End User Industry and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Therapy
  • Antipsychotic Drugs
  • Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants
  • Stimulants
  • Sleep Medications
  • Others

By Type
  • Autistic disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Others

By End User
  • Hospitals
  • Medical Institutions
  • Research and development centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing awareness and understanding of autism disorder, with the growing treatment options in the market
      • 3.2.2. Government initiatives towards the infrastructure for autism disorder treatment
    • 3.3. Market Challenges
      • 3.3.1. Difficulties in obtaining and covering the costs of these treatments
    • 3.4. Market Trends
      • 3.4.1. Growing emphasis on early diagnosis and intervention for individuals with autism disorder
      • 3.4.2. Increasing the integration of technology in autism treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Autism Disorder and Treatment-, by Therapy, Type, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Autism Disorder and Treatment- (Value)
      • 5.2.1. Global Autism Disorder and Treatment- by: Type (Value)
        • 5.2.1.1. Autistic disorder
        • 5.2.1.2. Asperger Syndrome
        • 5.2.1.3. Pervasive Developmental Disorder
        • 5.2.1.4. Others
      • 5.2.2. Global Autism Disorder and Treatment- by: Therapy (Value)
        • 5.2.2.1. Antipsychotic Drugs
        • 5.2.2.2. Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants
        • 5.2.2.3. Stimulants
        • 5.2.2.4. Sleep Medications
        • 5.2.2.5. Others
      • 5.2.3. Global Autism Disorder and Treatment- by: Type (Value)
        • 5.2.3.1. Autistic disorder
        • 5.2.3.2. Asperger Syndrome
        • 5.2.3.3. Pervasive Developmental Disorder
        • 5.2.3.4. Others
      • 5.2.4. Global Autism Disorder and Treatment- by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Medical Institutions
        • 5.2.4.3. Research and development centers
        • 5.2.4.4. Others
      • 5.2.5. Global Autism Disorder and Treatment- Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Autism Disorder and Treatment-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Curemark, LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Yamo Pharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. H. Lundbeck A/S (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allergan (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck & Co., Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Concern Pharma Private Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Johnson & Johnson Services, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bristol-Myers Squibb (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Autism Disorder and Treatment- Sale, by Therapy, Type, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Autism Disorder and Treatment- (Value)
      • 7.2.1. Global Autism Disorder and Treatment- by: Type (Value)
        • 7.2.1.1. Autistic disorder
        • 7.2.1.2. Asperger Syndrome
        • 7.2.1.3. Pervasive Developmental Disorder
        • 7.2.1.4. Others
      • 7.2.2. Global Autism Disorder and Treatment- by: Therapy (Value)
        • 7.2.2.1. Antipsychotic Drugs
        • 7.2.2.2. Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants
        • 7.2.2.3. Stimulants
        • 7.2.2.4. Sleep Medications
        • 7.2.2.5. Others
      • 7.2.3. Global Autism Disorder and Treatment- by: Type (Value)
        • 7.2.3.1. Autistic disorder
        • 7.2.3.2. Asperger Syndrome
        • 7.2.3.3. Pervasive Developmental Disorder
        • 7.2.3.4. Others
      • 7.2.4. Global Autism Disorder and Treatment- by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Medical Institutions
        • 7.2.4.3. Research and development centers
        • 7.2.4.4. Others
      • 7.2.5. Global Autism Disorder and Treatment- Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Autism Disorder and Treatment-: by Type(USD Billion)
  • Table 2. Autism Disorder and Treatment- Autistic disorder , by Region USD Billion (2018-2023)
  • Table 3. Autism Disorder and Treatment- Asperger Syndrome , by Region USD Billion (2018-2023)
  • Table 4. Autism Disorder and Treatment- Pervasive Developmental Disorder , by Region USD Billion (2018-2023)
  • Table 5. Autism Disorder and Treatment- Others , by Region USD Billion (2018-2023)
  • Table 6. Autism Disorder and Treatment-: by Therapy(USD Billion)
  • Table 7. Autism Disorder and Treatment- Antipsychotic Drugs , by Region USD Billion (2018-2023)
  • Table 8. Autism Disorder and Treatment- Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants , by Region USD Billion (2018-2023)
  • Table 9. Autism Disorder and Treatment- Stimulants , by Region USD Billion (2018-2023)
  • Table 10. Autism Disorder and Treatment- Sleep Medications , by Region USD Billion (2018-2023)
  • Table 11. Autism Disorder and Treatment- Others , by Region USD Billion (2018-2023)
  • Table 12. Autism Disorder and Treatment-: by Type(USD Billion)
  • Table 13. Autism Disorder and Treatment- Autistic disorder , by Region USD Billion (2018-2023)
  • Table 14. Autism Disorder and Treatment- Asperger Syndrome , by Region USD Billion (2018-2023)
  • Table 15. Autism Disorder and Treatment- Pervasive Developmental Disorder , by Region USD Billion (2018-2023)
  • Table 16. Autism Disorder and Treatment- Others , by Region USD Billion (2018-2023)
  • Table 17. Autism Disorder and Treatment-: by End User(USD Billion)
  • Table 18. Autism Disorder and Treatment- Hospitals , by Region USD Billion (2018-2023)
  • Table 19. Autism Disorder and Treatment- Medical Institutions , by Region USD Billion (2018-2023)
  • Table 20. Autism Disorder and Treatment- Research and development centers , by Region USD Billion (2018-2023)
  • Table 21. Autism Disorder and Treatment- Others , by Region USD Billion (2018-2023)
  • Table 22. South America Autism Disorder and Treatment-, by Country USD Billion (2018-2023)
  • Table 23. South America Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 24. South America Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 25. South America Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 26. Brazil Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 27. Brazil Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 28. Brazil Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 29. Argentina Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 30. Argentina Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 31. Argentina Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 32. Rest of South America Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 33. Rest of South America Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 34. Rest of South America Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 35. Asia Pacific Autism Disorder and Treatment-, by Country USD Billion (2018-2023)
  • Table 36. Asia Pacific Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 37. Asia Pacific Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 38. Asia Pacific Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 39. China Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 40. China Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 41. China Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 42. Japan Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 43. Japan Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 44. Japan Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 45. India Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 46. India Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 47. India Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 48. South Korea Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 49. South Korea Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 50. South Korea Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 51. Taiwan Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 52. Taiwan Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 53. Taiwan Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 54. Australia Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 55. Australia Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 56. Australia Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 57. Rest of Asia-Pacific Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 58. Rest of Asia-Pacific Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 59. Rest of Asia-Pacific Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 60. Europe Autism Disorder and Treatment-, by Country USD Billion (2018-2023)
  • Table 61. Europe Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 62. Europe Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 63. Europe Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 64. Germany Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 65. Germany Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 66. Germany Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 67. France Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 68. France Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 69. France Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 70. Italy Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 71. Italy Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 72. Italy Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 73. United Kingdom Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 74. United Kingdom Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 75. United Kingdom Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 76. Netherlands Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 77. Netherlands Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 78. Netherlands Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 79. Rest of Europe Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 80. Rest of Europe Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 81. Rest of Europe Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 82. MEA Autism Disorder and Treatment-, by Country USD Billion (2018-2023)
  • Table 83. MEA Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 84. MEA Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 85. MEA Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 86. Middle East Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 87. Middle East Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 88. Middle East Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 89. Africa Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 90. Africa Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 91. Africa Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 92. North America Autism Disorder and Treatment-, by Country USD Billion (2018-2023)
  • Table 93. North America Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 94. North America Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 95. North America Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 96. United States Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 97. United States Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 98. United States Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 99. Canada Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 100. Canada Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 101. Canada Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 102. Mexico Autism Disorder and Treatment-, by Therapy USD Billion (2018-2023)
  • Table 103. Mexico Autism Disorder and Treatment-, by Type USD Billion (2018-2023)
  • Table 104. Mexico Autism Disorder and Treatment-, by End User USD Billion (2018-2023)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Autism Disorder and Treatment-: by Type(USD Billion)
  • Table 116. Autism Disorder and Treatment- Autistic disorder , by Region USD Billion (2025-2030)
  • Table 117. Autism Disorder and Treatment- Asperger Syndrome , by Region USD Billion (2025-2030)
  • Table 118. Autism Disorder and Treatment- Pervasive Developmental Disorder , by Region USD Billion (2025-2030)
  • Table 119. Autism Disorder and Treatment- Others , by Region USD Billion (2025-2030)
  • Table 120. Autism Disorder and Treatment-: by Therapy(USD Billion)
  • Table 121. Autism Disorder and Treatment- Antipsychotic Drugs , by Region USD Billion (2025-2030)
  • Table 122. Autism Disorder and Treatment- Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants , by Region USD Billion (2025-2030)
  • Table 123. Autism Disorder and Treatment- Stimulants , by Region USD Billion (2025-2030)
  • Table 124. Autism Disorder and Treatment- Sleep Medications , by Region USD Billion (2025-2030)
  • Table 125. Autism Disorder and Treatment- Others , by Region USD Billion (2025-2030)
  • Table 126. Autism Disorder and Treatment-: by Type(USD Billion)
  • Table 127. Autism Disorder and Treatment- Autistic disorder , by Region USD Billion (2025-2030)
  • Table 128. Autism Disorder and Treatment- Asperger Syndrome , by Region USD Billion (2025-2030)
  • Table 129. Autism Disorder and Treatment- Pervasive Developmental Disorder , by Region USD Billion (2025-2030)
  • Table 130. Autism Disorder and Treatment- Others , by Region USD Billion (2025-2030)
  • Table 131. Autism Disorder and Treatment-: by End User(USD Billion)
  • Table 132. Autism Disorder and Treatment- Hospitals , by Region USD Billion (2025-2030)
  • Table 133. Autism Disorder and Treatment- Medical Institutions , by Region USD Billion (2025-2030)
  • Table 134. Autism Disorder and Treatment- Research and development centers , by Region USD Billion (2025-2030)
  • Table 135. Autism Disorder and Treatment- Others , by Region USD Billion (2025-2030)
  • Table 136. South America Autism Disorder and Treatment-, by Country USD Billion (2025-2030)
  • Table 137. South America Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 138. South America Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 139. South America Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 140. Brazil Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 141. Brazil Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 142. Brazil Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 143. Argentina Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 144. Argentina Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 145. Argentina Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 146. Rest of South America Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 147. Rest of South America Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 148. Rest of South America Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 149. Asia Pacific Autism Disorder and Treatment-, by Country USD Billion (2025-2030)
  • Table 150. Asia Pacific Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 151. Asia Pacific Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 152. Asia Pacific Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 153. China Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 154. China Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 155. China Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 156. Japan Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 157. Japan Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 158. Japan Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 159. India Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 160. India Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 161. India Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 162. South Korea Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 163. South Korea Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 164. South Korea Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 165. Taiwan Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 166. Taiwan Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 167. Taiwan Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 168. Australia Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 169. Australia Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 170. Australia Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 171. Rest of Asia-Pacific Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 172. Rest of Asia-Pacific Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 173. Rest of Asia-Pacific Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 174. Europe Autism Disorder and Treatment-, by Country USD Billion (2025-2030)
  • Table 175. Europe Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 176. Europe Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 177. Europe Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 178. Germany Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 179. Germany Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 180. Germany Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 181. France Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 182. France Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 183. France Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 184. Italy Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 185. Italy Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 186. Italy Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 187. United Kingdom Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 188. United Kingdom Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 189. United Kingdom Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 190. Netherlands Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 191. Netherlands Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 192. Netherlands Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 193. Rest of Europe Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 194. Rest of Europe Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 195. Rest of Europe Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 196. MEA Autism Disorder and Treatment-, by Country USD Billion (2025-2030)
  • Table 197. MEA Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 198. MEA Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 199. MEA Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 200. Middle East Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 201. Middle East Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 202. Middle East Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 203. Africa Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 204. Africa Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 205. Africa Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 206. North America Autism Disorder and Treatment-, by Country USD Billion (2025-2030)
  • Table 207. North America Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 208. North America Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 209. North America Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 210. United States Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 211. United States Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 212. United States Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 213. Canada Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 214. Canada Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 215. Canada Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 216. Mexico Autism Disorder and Treatment-, by Therapy USD Billion (2025-2030)
  • Table 217. Mexico Autism Disorder and Treatment-, by Type USD Billion (2025-2030)
  • Table 218. Mexico Autism Disorder and Treatment-, by End User USD Billion (2025-2030)
  • Table 219. Research Programs/Design for This Report
  • Table 220. Key Data Information from Secondary Sources
  • Table 221. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Autism Disorder and Treatment-: by Type USD Billion (2018-2023)
  • Figure 5. Global Autism Disorder and Treatment-: by Therapy USD Billion (2018-2023)
  • Figure 6. Global Autism Disorder and Treatment-: by Type USD Billion (2018-2023)
  • Figure 7. Global Autism Disorder and Treatment-: by End User USD Billion (2018-2023)
  • Figure 8. South America Autism Disorder and Treatment- Share (%), by Country
  • Figure 9. Asia Pacific Autism Disorder and Treatment- Share (%), by Country
  • Figure 10. Europe Autism Disorder and Treatment- Share (%), by Country
  • Figure 11. MEA Autism Disorder and Treatment- Share (%), by Country
  • Figure 12. North America Autism Disorder and Treatment- Share (%), by Country
  • Figure 13. Global Autism Disorder and Treatment- share by Players 2023 (%)
  • Figure 14. Global Autism Disorder and Treatment- share by Players (Top 3) 2023(%)
  • Figure 15. Global Autism Disorder and Treatment- share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 19. Curemark, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 20. Curemark, LLC (United States) Revenue: by Geography 2023
  • Figure 21. Yamo Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 22. Yamo Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 23. H. Lundbeck A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 24. H. Lundbeck A/S (Denmark) Revenue: by Geography 2023
  • Figure 25. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. Allergan (Ireland) Revenue: by Geography 2023
  • Figure 29. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Concern Pharma Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 32. Concern Pharma Private Limited (India) Revenue: by Geography 2023
  • Figure 33. Johnson & Johnson Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Johnson & Johnson Services, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Bristol-Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 36. Bristol-Myers Squibb (United States) Revenue: by Geography 2023
  • Figure 37. Global Autism Disorder and Treatment-: by Type USD Billion (2025-2030)
  • Figure 38. Global Autism Disorder and Treatment-: by Therapy USD Billion (2025-2030)
  • Figure 39. Global Autism Disorder and Treatment-: by Type USD Billion (2025-2030)
  • Figure 40. Global Autism Disorder and Treatment-: by End User USD Billion (2025-2030)
  • Figure 41. South America Autism Disorder and Treatment- Share (%), by Country
  • Figure 42. Asia Pacific Autism Disorder and Treatment- Share (%), by Country
  • Figure 43. Europe Autism Disorder and Treatment- Share (%), by Country
  • Figure 44. MEA Autism Disorder and Treatment- Share (%), by Country
  • Figure 45. North America Autism Disorder and Treatment- Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Novartis AG (Switzerland)
  • Curemark, LLC (United States)
  • Yamo Pharmaceuticals (United States)
  • H. Lundbeck A/S (Denmark)
  • Pfizer Inc. (United States)
  • Allergan (Ireland)
  • Merck & Co., Inc. (United States)
  • Concern Pharma Private Limited (India)
  • Johnson & Johnson Services, Inc. (United States)
  • Bristol-Myers Squibb (United States)
Additional players considered in the study are as follows:
PaxMedica (United States) , Hoffmann-La Roche Ltd (Switzerland) , Aurobindo Pharma Ltd. (India) , Otsuka Holdings Co. Ltd. (Japan) , Janssen Pharmaceuticals, Inc. (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 217 Pages 88 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Autism Disorder and Treatment- Market Quantitative research analysis
Global Autism Disorder and Treatment- Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Novartis AG (Switzerland), Curemark, LLC (United States), Yamo Pharmaceuticals (United States), H. Lundbeck A/S (Denmark), Pfizer Inc. (United States), Allergan (Ireland), Merck & Co., Inc. (United States), Concern Pharma Private Limited (India), Johnson & Johnson Services, Inc. (United States) and Bristol-Myers Squibb (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing emphasis on early diagnosis and intervention for individuals with autism disorder " is seen as one of major influencing trends for Autism Disorder and Treatment- Market during projected period 2023-2030.
The Autism Disorder and Treatment- market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Autism Disorder and Treatment- Market Report?

Have a Query? Click Here

Other Related Reports

Bone Pain Treatment- Comprehensive Study by Treatment (Therapies, Surgery, Antibiotics, Others), Indication (Injury, Trauma, Bone Tumour, Infection, Others), End User (Hospital, Speciality Clinics, ...
$ 3800
Hemianopsia- Comprehensive Study by Type (Bitemporal, Homonymous, Heteronymous, Superior, Inferior, Others), Treatment (Vision Restoration Therapy (VRT), Visual Field Expander Aid, Visual Auditory Tr...
$ 3800
Allergic Rhinitis- Comprehensive Study by Type (Perennial Allergic Rhinitis, Seasonal Allergic Rhinitis, Occupational Allergic Rhinitis), Treatment (Immunotherapy, Antihistamines, Decongestant, Corti...
$ 3800
Anophthalmia and Microphthalmia Comprehensive Study by Application (Hospitals, Speciality Clinics, Research Center, Others), Treatment (Surgical Interventions, Prosthetic Devices, Gene Therapy, Pharm...
$ 3800
Thyroid Disorder Therapy Comprehensive Study by Drug Type (Kinase Inhibitors, Anthracyclines, Beta-Blockers, Others), Disease Type (Hypothyroidism, Hyperthyroidism, Goiter, Hashimoto Disease, Others)...
$ 3800
Depression Therapeutics- Comprehensive Study by Indication Type (Major depressive disorder (MDD), Bipolar disorder, Dysthymic disorder, Postpartum depression, Seasonal affective disorder (SAD), Preme...
$ 3800